Drs. Hidehito Horinouchi and Stephen Liu will chair the session, which will explore multiple advances driving survival gains, including antibody-drug conjugates, bispecific T-cell engagers, and targeted therapies. Read more
Members are invited to join the meeting and learn about the new plan, which will guide the association for the next 5 years. Read more
In addition to thought-provoking keynotes from Her Royal Highness Princess Dina Mired and Dr. Gary Rodin, the official kickoff of #WCLC23 included a lively celebration of the meeting’s host city. Read more
Investigator Dr. Ying Cheng says study results support the use of immunochemotherapy plus anti-angiogenesis as a new treatment option in a difficult-to-treat patient population. Read more
Make time to visit the Exhibit Hall this evening to talk with poster presenters about their research. Read more
The symposium also marks a change in IASLC leadership as Dr. Heather Wakelee will deliver the final Presidential Address of her term. Read more
IASLC Staging and Prognostic Factors Committee Chair Dr. Hisao Asamura joins Drs. Valerie Rusch and Enrico Ruffini to review updates in lung cancer, mesothelioma, and thymic cancer. Read more
The IASLC Cancer Care Team award highlights the teamwork required to provide the best possible patient care. Read more
Since WCLC 2022, JTO, led by Dr. Alex A. Adjei, has continued to increase its impact factor, and JTO CRR has welcomed a new Editor-in-Chief, Dr. Emily Stone. Read more
In an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more. Read more